GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+80.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
666
New
Increased
Reduced
Closed

Top Buys

1
+$142M
2
+$117M
3
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

1
+$81.3M
2
+$72.3M
3
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRX icon
351
Amneal Pharmaceuticals
AMRX
$4.31B
$87.8K ﹤0.01%
7,060
+882
LPX icon
352
Louisiana-Pacific
LPX
$4.98B
$87.3K ﹤0.01%
+1,200
CNTA
353
Centessa Pharmaceuticals
CNTA
$6.16B
$86K ﹤0.01%
2,166
+271
HR icon
354
Healthcare Realty
HR
$6.78B
$85.8K ﹤0.01%
5,049
-485
INDV icon
355
Indivior Pharmaceuticals
INDV
$4.43B
$85.5K ﹤0.01%
2,804
+351
ACAD icon
356
Acadia Pharmaceuticals
ACAD
$3.72B
$84.6K ﹤0.01%
3,799
+475
RHP icon
357
Ryman Hospitality Properties
RHP
$7.39B
$83.6K ﹤0.01%
906
-86
KRG icon
358
Kite Realty
KRG
$5.54B
$81.6K ﹤0.01%
3,323
-320
NAMS icon
359
NewAmsterdam Pharma
NAMS
$3.82B
$81.5K ﹤0.01%
2,546
+318
BRK.B icon
360
Berkshire Hathaway Class B
BRK.B
$1.03T
$80.5K ﹤0.01%
168
-9,876
CRNX icon
361
Crinetics Pharmaceuticals
CRNX
$3.65B
$77.4K ﹤0.01%
2,131
+267
DLTR icon
362
Dollar Tree
DLTR
$21B
$76.7K ﹤0.01%
700
EWTX icon
363
Edgewise Therapeutics
EWTX
$4.01B
$74.9K ﹤0.01%
2,378
+299
GPCR icon
364
Structure Therapeutics
GPCR
$2.78B
$72.3K ﹤0.01%
1,500
+188
MAC icon
365
Macerich
MAC
$6.58B
$72.2K ﹤0.01%
3,820
-368
MRSH
366
Marsh
MRSH
$77.7B
$72K ﹤0.01%
415
PECO icon
367
Phillips Edison & Co
PECO
$4.94B
$71.1K ﹤0.01%
1,900
-181
SBRA icon
368
Sabra Healthcare REIT
SBRA
$4.46B
$69.7K ﹤0.01%
3,624
-349
TARS icon
369
Tarsus Pharmaceuticals
TARS
$2.6B
$66.9K ﹤0.01%
953
+120
SUPN icon
370
Supernus Pharmaceuticals
SUPN
$2.59B
$66.6K ﹤0.01%
1,288
+162
IDYA icon
371
IDEAYA Biosciences
IDYA
$2.57B
$65.6K ﹤0.01%
1,969
+247
TWST icon
372
Twist Bioscience
TWST
$4.6B
$65.2K ﹤0.01%
1,373
+172
RIO icon
373
Rio Tinto
RIO
$171B
$64.9K ﹤0.01%
696
+693
ARQT icon
374
Arcutis Biotherapeutics
ARQT
$2.75B
$64.8K ﹤0.01%
2,751
+345
VNO icon
375
Vornado Realty Trust
VNO
$6.57B
$64.1K ﹤0.01%
2,468
-237
13 14
15
16 17